Oncology Support
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Access global oncology support market intelligence. Drive strategic BD, investment & regulatory insights for pharma. Stay ahead in cancer care innovation.
Showing 1–7 of 7 articles
Quick answer
NovaPharmaNews Oncology Support hub for FDA covers 7 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Revolution Medicine Pancreatic Cancer: Demand Surge Strains Daraxonrasib Access
Arvinas VEPPANU (Vepdegestrant) Receives FDA Approval as First PROTAC Drug for ESR1-Mutated Breast Cancer
FDA Approves Incyte's Jakafi XR Extended-Release Tablets for Myelofibrosis, Polycythemia Vera Treatment
FDA Accelerated Approval Pathway: Impact on Oncology Drug Development & Market Access 2026
ASCO 2026: Top Oncology Trials to Watch
Pembrolizumab KEYNOTE-826 Trial: Expanded Use in Advanced Cervical Cancer
AACR 2026: Pembrolizumab Bowel Cancer Success, Moderna Melanoma Data
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.